Accreditation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABPLM Designation Statement: This internet enduring material has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1 clinical hour toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM. Each physician should claim only those hours of credit actually spent on the activity.
Session Description: This session will be an interactive session utilizing mini case vignettes that will exemplify areas for pharmacist-physician collaboration. The American Geriatric Society’s revised Beers Criteria will be discussed when relevant, and physiological and pharmacological reasons for the cited drug interactions will be presented in an evidence-based manner.
Define the altered physiology of aging that makes older adults more susceptible to drug-drug interactions.
Discuss three common and clinically significant drug-drug interactions (using a case-based approach) that are encountered in each of these clinical areas: cardiovascular disease, psychiatry and pain management.
Demonstrate an understanding of mechanisms of drug-drug interactions including CYP450 enzyme induction and inhibition, and drug-gene (pharmacogenetics).
Enumerate three physician-pharmacist communication strategies to minimize the potential for drug interactions in the PA/LTC setting.
Speaker(s): Naushira Pandya, MD, CMD Manju T. Beier, PharmD, CGP
Disclosure(s): Manju Beier: Has a financial disclosure: Sunovion Pharmaceutical:speaker and consultant; Lundbeck Pharmaceutical:speaker and consultant.